It’s long been known that high blood pressure can lead to cardiovascular disease. Now, regulators are looking for a connection between blood pressure and cardiovascular events during drug therapy. As a result, new FDA draft guidance advises sponsors to assess a drug’s effect on blood pressure.
The best and most patient-friendly way to collect blood pressure data during a clinical trial is ambulatory blood pressure monitoring or ABPM. Read on to learn more about implementing ABPM and its benefits for patients, sites, and sponsors.
REQUEST A DEMO
Our team of experts is here to address any of your questions. Submit your contact information and we’ll be in touch to schedule a demo or meeting.